Muir Torre syndrome: clinical features and molecular genetic analysis
|
|
- Donald Farmer
- 6 years ago
- Views:
Transcription
1 British Journal of Dermatology 1997; 136: Muir Torre syndrome: clinical features and molecular genetic analysis C.ESCHE, R.KRUSE,* C.LAMBERTI,* W.FRIEDL,* P.PROPPING,* P.LEHMANN AND T.RUZICKA Department of Dermatology, Heinrich-Heine-University, Moorenstrasse 5, Duesseldorf, Germany *Institute of Human Genetics, Friedrich-Wilhelms-University, Wilhelmstrasse 31, Bonn, Germany Accepted for publication 7 January 1997 Summary We report a 62-year-old man with rectal cancer, two keratoacanthomas and multiple sebaceous adenomas, epitheliomas and sebaceous hyperplasia. His brother and father died from colorectal cancer. A subgroup of patients with the Muir Torre syndrome (MTS) is allelic to the cancer family syndrome. This genetic disorder is caused by an autosomal dominant inherited germline mutation in one of the DNA mismatch repair genes. It is thought that a somatic mutation of the other allele leads to a genomic instability responsible for tumorigenesis. In the patient presented here the instability was detected in two characteristic skin lesions; sebaceous adenoma and epithelioma. The search for a causal germline mutation revealed a frameshift mutation in the mismatch repair gene hmsh2 leading to a truncated protein. A presymptomatic molecular diagnosis can be offered to the children of the patient. The Muir Torre syndrome (MTS) is an autosomal dominant inherited predisposition to internal and cutaneous tumours. 1 It has been shown that a subgroup is allelic to the cancer family syndrome (CFS), hereditary non-polyposis colorectal cancer (HNPCC). 2,3 In tumour tissues of both the MTS subgroup and HNPCC a genomic replication error known as microsatellite instability (MIN) is striking. 4,5 The instability is caused by alterations in at least one of four DNA mismatch repair genes. 5 9 These genes play a crucial role in the correction of mismatched base pairs. Mismatches physiologically originate from replication of the DNA during the cell cycle. For the repair mechanism an interaction of proteins coded by at least five different mismatch repair genes is essential. 10 In a study of 48 HNPCC patients, germline mutations in the mismatch repair genes hmlh1 or hmsh2 have been detected in 33 or 31% of the patients, respectively, and mutations in the hpms1 or hpms2 in 6%. 5 In MTS a germline mutation in the hmlh1 gene has been described in only one family, 11 while the great majority of Muir Torre patients have germline mutations in the hmsh2 gene. 8,12 The predisposition to tumours in distinctive tissues is caused by a heterozygous germline mutation in one of the DNA mismatch repair genes. It is thought that an Correspondence: Dr T.Ruzicka British Association of Dermatologists additional somatic mutation of the other allele leads to a loss of mismatch repair and so can result in a subsequent manifestation of a tumour. Thus a defective mismatch repair gene is recessive at the cellular level. After further cell cycles, accumulated base pair mismatches can lead to a large number of somatic mutations in several loci of the whole genome. These alterations can be demonstrated by an instability of individual DNA microsatellites (MIN). If oncogenes and/or tumour-suppressor genes are also mutated then a neoplasm can develop. 13 Why colonic epithelium and sebaceous glands are affected predominantly, remains unclear. While most of the internal tumours of HNPCC patients show MIN, 14 the actual frequency of MIN in the different types of skin tumours associated with the MTS is still unknown. Case report A 62-year-old man presented with 3-year history of facial papules. These measured 2 4 mm and were yellow or skin-coloured (Fig. 1). Approximately 3 months prior to presentation the patient noted the onset of two enlarging lesions on the left nostril and below the left nipple. On examination, round tumours with a central indentation were seen. These averaged cm in diameter. Histological examination showed 913
2 914 C.ESCHE et al. Figure 1. A 62-year-old with 3-year history of facial papules. kerathoacanthoma. The biopsies of 16 facial papules showed sebaceous adenoma, epithelioma and hyperplasia. At the age of 57 years a rectal carcinoma Dukes stage B was excised. The patient s father and brother also had colorectal cancer, but had no skin tumours. The brother died at the age of 33. The three children of the patient are healthy, and have decided against knowing their carrier status or having further investigations. Molecular genetic analysis Paraffin-embedded tissues from three different skin tumours (sebaceous adenoma and epithelioma, keratoacanthoma) were examined for MIN. Genomic DNA from tumours was extracted with the QIAamp tissue kit (QIAGEN). The normal DNA was isolated from peripheral blood by the salting out procedure. Subsequently, pairs of tumour and normal DNA were amplified by PCR with up to 10 microsatellite markers. The electrophoretic mobilities of the corresponding amplification Figure 2. Microsatellite instability (MIN) in skin tumours of the patient. DNA from peripheral blood (N) and tumour tissues (SA, sebaceous adenoma; SE, sebaceous epithelioma; KA, keratoacanthoma) were examined with the microsatellite marker D2S136. Additional alleles in the sebaceous tumours are marked by arrowheads. products were compared on polyacrylamide gels. Microsatellite instability was observed in both the sebaceous adenoma and the sebaceous epithelioma with three and four microsatellite markers, respectively. The keratoacanthoma did not show instability with 10 markers tested (Fig. 2). Tissue from the colon carcinoma was not available.
3 MUIR TORRE SYNDROME 915 Figure 3. Heteroduplex analysis of exon 2 of the hmsh2 gene. DNA of controls (lanes 1 6) and patient (lanes 7 and 8) was amplified by polymerase chain reaction (PCR), separated by polyacrylamide gel electrophoresis and visualized by silver staining. An aberrant pattern is observed in the patient: in addition to the normal homoduplex (286 bp) a second homoduplex band at 308 bp (due to an insertion) and two slower migrating heteroduplex bands (het) are shown (M, 100 bp ladder). To screen for germline mutations in the mismatch repair genes we applied non-radioactive heteroduplex analysis and single strand conformational analysis (SSCA) as described. 15 A variant SSCA and heteroduplex pattern was observed in exon 2 of the hmsh2 gene (Fig. 3). Sequencing revealed an insertion of 22 base pairs at codon 97 (Fig. 4). This frameshift mutation (289ins22) leads to a stop codon after nine further codons and thus to a truncated hmsh2 protein. Discussion In April 1958 Smith presented a 33-year-old man with multiple keratoacanthomas and sebaceous hyperplasia of the face during a meeting of the Dermatological Section of the Royal Society of Medicine. 16 In March 1967 Muir et al. reported the same patient, who in the meantime had developed four carcinomas of the colon, Figure 4. Autoradiography showing the sequence of the antisense strand of exon 2 of the hmsh2 gene. A heterozygous insertion of 22 base pairs at codon 97 (after base pair 289) leads to a frameshift with a stop after nine further codons. The site of insertion is marked by an arrow.
4 916 C.ESCHE et al. two of the duodenum and one of the larynx. 17 In October 1967 Torre et al. presented a 57-year-old man with more than 100 sebaceous adenomas or carcinoma, respectively, on the face, scalp and trunk to the New York Dermatological Society. 18 The case history revealed carcinoma of colon and papilla vateri. In 1971, Bakker et al. reported a third case and considered that the three patients represented a rare syndrome. 19 In 1974 the designation Torre s syndrome was proposed. 20 Since then the name Muir Torre syndrome has been accepted. Criteria for diagnosis as reviewed by Schwartz et al. 1 are at least one visceral cancer and one sebaceous gland tumour; either adenoma, epithelioma or carcinoma (in decreasing order of frequency). Sebaceous hyperplasia and nevi sebacei of Jadassohn are not diagnostic. The same applies to keratoacanthoma, which occurs in 20% of MTS cases. Fifty-one per cent of the patients develop at least one colorectal carcinoma, which occurs on the average 10 years earlier than in the general population. Twenty-four per cent of the patients develop genitourinary cancer. Sixty per cent of the cases of MTS occur in men and in 60% the internal neoplasia is the first sign. 1 The differential diagnosis includes Gardner s syndrome (epidermal cysts, fibromas, colon adenomatosis, osteomas, retinal pigmentation), Cowden s syndrome (facial trichilemmomas, oral papules, acral fibromas, carcinoma of breast, thyroid gland, stomach and bowels), Goltz Gorlin syndrome (multiple basaliomas, jaw cysts with tendency to malignant transformation, broad bridge of the nose, ovary fibromas, hypertelorism), multiple self-healing keratoacanthoma (Ferguson Smith type), generalized eruptive keratoacanthoma (Grzybowski type), multiple trichoepitheliomata and Bourneville Pringle disease (adenoma sebaceum, epileptiform attacks, mental defects). Treating the cause of the MTS is not currently possible. 21 Any skin tumour should be excised. Prevention can be tried with oral isotretinoin up to 0. 8 mg/kg per day. 22 Although the cancers in this syndrome are less aggressive, a periodic search for visceral cancer is recommended for patients and relatives from the age of 25. The family history of the patient presented here reveals two first-degree relatives with colorectal cancer. One of them died at 33 years of age. Thus the family structure fitted previous criteria (Amsterdam criteria) for HNPCC. 23 Our patient was diagnosed as having MTS since he had characteristic sebaceous tumours in addition to rectal carcinoma. Using periodic acid Schiff (PCR) techniques microsatellite instability in the two typical sebaceous skin lesions was found in this patient. This suggested the existence of a DNA mismatch repair defect. The keratoacanthoma did not show genomic instability. This observation is in agreement with data of Halling et al. 24 who found MIN only in part of the keratoacanthoma both in randomly selected patients and in patients with additional visceral tumours, including MTS. A mutation analysis revealed an insertion of 22 base pairs in exon 2 of the DNA mismatch repair gene hmsh2. The resulting frameshift is predicted to lead to the synthesis of a considerably truncated mismatch repair protein. The identification of a germline mutation in the DNA mismatch repair gene hmsh2, in addition to the clinical feature and the microsatellite instability in tumour tissues, confirms the diagnosis of MTS in the family presented here. For the three adult children of the patient, who have an a priori risk of 50% to inherit the cancer predisposition, a presymptomatic molecular diagnosis can be offered. For those children who have not inherited the germline mutation in the hmsh2 gene strict cancer surveillance is not necessary, while those who have inherited the mutation must undergo regular examinations especially of the skin, the colon and the genitourinary tract as recommended by Cohen et al. 25 However, it has to be kept in mind that the predictive diagnosis of a tumour predisposition may have deep psychological implications. The identification of a germline mutation implies that this still healthy person is at high risk to develop a disease-associated tumour; but it is not known, if, when or in which tissue a tumour will arise. Therefore, each predictive diagnosis should be preceded by a careful genetic counselling that includes full information on the possibilities and limits, as well as on the consequences of a predictive test. Acknowledgments We thank Marlies Sengteller for excellent technical assistance. The molecular genetic investigations were supported by the Deutsche Krebshilfe. RK is a research fellow of the Deutsche Forschungsgemeinschaft. References 1 Schwartz RA, Torre DP. The Muir Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995; 33: Hall NR, Murday VA, Chapman P et al. Genetic linkage in Muir Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994; 30A(2): Hall NR, Williams MAT, Murday VA et al. Muir Torre syndrome: a variant of the cancer family syndrome. J Med Genet 1994; 31:
5 MUIR TORRE SYNDROME Honchel R, Halling KC, Schaid DJ et al. Microsatellite instability in Muir Torre syndrome. Cancer Res 1994; 54: Liu B, Parsons R, Papadopoulos N et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nature Med 1996; 2: Bronner CE, Baker SM, Morrison PT et al. Mutation in the DNA mismatch repair gene homologue hmlh1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: Fishel R, Lescoe MK, Rao MRS et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: Kolodner RD, Hall NR, Lipford J et al. Structure of the human MSH2 locus and analysis of two Muir Torre kindreds for MSH2 mutations. Genomics 1994; 24: Nicolaides NC, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: Palombo F, Gallinari P, Iaccarino I et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995; 268: Bapat B, Xia L, Madlensky L et al. The genetic basis of Muir Torre syndrome includes the hmlh1 locus. Am J Hum Genet 1996; 59: Kruse R, Lamberti C, Wang Yet al. Is the mismatch repair deficient type of Muir Torre syndrome confined to mutations in the hmsh2 gene? Hum Genet 1996; 98: Lazar V, Grandjouan S, Bognel C et al. Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 1994; 3: Aaltonen LA, Peltomäki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: Wehner M, Buschhausen L, Lamberti C et al. Hereditary nonpolyposis colorectal cancer (HNPCC): Eight novel germline mutations in the hmsh2 or hmlh1 genes. Hum Mutation 1996 (in press). 16 Smith PAJ. Multiple sebaceous papillomas. Proc R Soc Med 1958; 51: Muir EG, Bell AJY, Barlow KA. Multiple primary carcinomata of the colon, duodenum and larynx associated with keratoacanthomas of the face. Br J Surg 1967; 54: Torre D. Society transactions: New York Dermatological Society, Oct 24, 1967 (multiple sebaceous tumors). Arch Dermatol 1968; 98: Bakker PM, Tjon A, Joe SS. Multiple sebaceous gland tumours, with multiple tumours of internal organs: a new syndrome? Dermatologica 1971; 142: Bitran J, Pellettiere EV. Multiple sebaceous gland tumours and internal carcinoma: Torre s syndrome. Cancer 1974; 33: Hartig C, Stieler W, Stadler R. Muir Torre-Syndrom. Hautarzt 1995; 46: Spielvogel RL, DeVillez RL, Roberts LC. Oral isotretinoin therapy for familial Muir Torre syndrome. J Am Acad Dermatol 1985; 12: Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. The International Collaborative Group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 1991; 34: Halling KC, Honchel R, Pittelkow MR, Thibodeau N. Microsatellite instability in keratoacanthoma. Cancer 1995; 15: Cohen PR, Kohn SR, Kurzrock SR. Association of sebaceous gland tumors and internal malignancy: the Muir Torre syndrome. Am J Med 1991; 90:
Familial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationCélia DeLozier-Blanchet
The Genetics Consultation in OB-GYN : Hereditary cancers Célia DeLozier-Blanchet Division of Medical Genetics, Geneva University Hospital It is probable that all cancers are genetic! genetic vs. hereditary
More informationThe Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families
BRIEF COMMUNICATION The Frequency of Muir-Torre Syndrome Among Lynch Syndrome Families Christopher D. South, Heather Hampel, Ilene Comeras, Judith A. Westman, Wendy L. Frankel, Albert de la Chapelle Lynch
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014
Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October
More informationCutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm
J Cuton Patkol2009: 36: 613-619 doi: 1O.1111/j.1600-0560.2009.01248.x Jokn Wilry & Sons. Printed in Singapore Copyright 2009 John Wliey & Sons AI Journal of Cutaneous Pathology Continuing Medical Education
More informationcolorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018
colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast
More informationWhat All of Us Should Know About Cancer and Genetics
What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships
More informationRNA-Based Mutation Screening in Hereditary Nonpolyposis
RNA-Based Mutation Screening in Hereditary Nonpolyposis Colorectal Cancer Maija Kohonen-Corish,' Veronica L. Ross,' William F. Doe,' Deborah A. KooI,2 Edward Edkins,2 Ian Faragher,3 Juul Wijnen,5 P. Meera
More informationContent. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome
of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines
More informationHereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics
From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of
More informationM uir-torre syndrome (MTS; MIM ) is an
567 LETTER TO JMG A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir- Torre syndrome E Mangold, C Pagenstecher, M Leister, M Mathiak, A Rütten, W
More informationKeywords: microsatellite instability; multiple primary cancer; hereditary non-polyposis colorectal cancer
790 Gut 2000;46:790 794 First Department of Internal Medicine, Sapporo Medical University, Sapporo, K Yamashita Y Arimura S Kurokawa F Itoh T Endo K Imai First Department of Surgery, Sapporo Medical University,
More informationManagement of higher risk of colorectal cancer. Huw Thomas
Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)
More informationLynch Syndrome. Angie Strang, PGY2
Lynch Syndrome Angie Strang, PGY2 Background Previously hereditary nonpolyposis colorectal cancer Autosomal dominant inherited cancer susceptibility syndrome Caused by defects in the mismatch repair system
More informationThe Impact of Presymptomatic Molecular Testing in Hereditary Cancers
Review Med Principles Pract 2000;9:221 248 The Impact of Presymptomatic Molecular Testing in Hereditary Cancers Fiona Macdonald DNA Laboratory, Regional Genetics Laboratory, Birmingham Women s Hospital,
More informationPractice Gaps: Essential Genetics
FRM F017 Practice Gaps: Essential Genetics Jennifer L. Hand MD Associate Professor of Dermatology, Clinical Genomics, and Pediatrics Section Head, Dermatology Genetics Mayo Clinic, Rochester, MN, USA DISCLOSURE
More informationDuring the past decade the genetic etiology of all of. Genetic Testing for Inherited Colon Cancer
GASTROENTEROLOGY 2005;128:1696 1716 Genetic Testing for Inherited Colon Cancer RANDALL BURT*, and DEBORAH W. NEKLASON*, *Huntsman Cancer Institute, Salt Lake City; and Departments of Medicine and Oncological
More informationGenetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationT he lifetime risk of developing colorectal cancer is 5%, with. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer CANCER
228 CANCER Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer G Lindgren, A Liljegren, E Jaramillo, C Rubio, A Lindblom... See end of article for authors affiliations... Correspondence
More informationSEBACEOUS NEOPLASMS. Dr. Prachi Saraogi Clinical Fellow in Dermatology
SEBACEOUS NEOPLASMS Dr. Prachi Saraogi Clinical Fellow in Dermatology Sebaceous neoplasms Sebaceous adenoma (Benign) Sebaceous carcinoma (Malignant) SEBACEOUS ADENOMA Benign tumours composed of incompletely
More informationCancer Genomics 101. BCCCP 2015 Annual Meeting
Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic
More informationGenetic linkage analysis in hereditary
352 35 Med Genet 1995;32:352-357 Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome Cambridge niversity Department of Pathology, Box 134, Addenbrooke's Hospital, Hills Road, Cambridge
More informationAnalysis of genetic changes in cutaneous lesions in
Microsatellite Instability in Benign Skin Lesions in Hereditary Non-Polyposis Colorectal Cancer Syndrome Victoria J. Swale, Anthony G. Quinn, James M. Wheeler,* Nicholas E. Beck,* Isis Dove-Edwin,² Huw
More informationDevelopment of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationCowden Syndrome PTEN Hamartoma Tumor Syndrome. ACCME/Disclosure. 1. Background. Outline
MASSACHUSETTS GENERAL HOSPITAL HARVARD MEDICAL SCHOOL PATHOLOGY Cowden Syndrome PTEN Hamartoma Tumor Syndrome ACCME/Disclosure Vania Nosé, MD, PhD Professor of Pathology Director of Anatomic Pathology
More informationA Review from the Genetic Counselor s Perspective
: A Review from the Genetic Counselor s Perspective Erin Sutcliffe, MS, CGC Certified Genetic Counselor Cancer Risk Evaluation Program INTRODUCTION Errors in base pair matching that occur during DNA replication,
More informationGENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department
GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY
More informationCOLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University
COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.
More informationFACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?
Important points The most important factors that can influence an individual s chance of developing bowel cancer are getting older and having a family history of bowel cancer A family history of bowel
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationColorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi
Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change
More informationThe Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto
Immunohistochemical Assessment of Mismatch Repair Proteins in Endometrial Cancer: The Whys and How Terence J. Colgan, MD Head of Gynaecological Pathology, Mount Sinai Hospital, University of Toronto, Toronto.
More informationCLINICAL FINDINGS WITH IMPLICATIONS FOR GENETIC TESTING IN FAMILIES WITH CLUSTERING OF COLORECTAL CANCER
CLINICAL FINDINGS WITH IMPLICATIONS FOR GENETIC TESTING IN FAMILIES WITH CLUSTERING OF COLORECTAL CANCER CLINICAL FINDINGS WITH IMPLICATIONS FOR GENETIC TESTING IN FAMILIES WITH CLUSTERING OF COLORECTAL
More informationYes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationClassification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes
Hereditary polyposis syndromes Classification of polyposis syndromes two major groups adenomatous and non-adenomatous polyposis syndromes Adenomatous polyposis syndromes Familial adenomatous polyposis(fap)
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationClinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability
The Korean Journal of Pathology 29; 43: 428-34 DOI: 1.4132/KoreanJPathol.29.43.5.428 Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability Sang Kyum Kim Junjeong
More informationProactive Patient Paves the Way for Genetic Testing of Eight Family Members
CASE STUDY Proactive Patient Paves the Way for Genetic Testing of Eight Family Members Quick Summary Samar Mohite * was diagnosed with colon adenocarcinoma at the age of 49 years. Genetic counselling was
More informationHow common are mutations in the MSH2 gene? 1. Mutations that cause Lynch syndrome are rare found in approximately 1 in 370 individuals.
The gene is a tumor suppressor gene. Tumor suppressor genes slow down cell division, repair DNA mistakes, or tell cells when to die. When they don't work properly, cells can grow out of control, which
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationPathology reports, related operative reports and consult letters must be provided with a request for assessment.
Page 1 of 6 Polyposis Syndromes Inherited risk for colorectal cancer is associated with a number of polyposis syndromes (genes), some of which are well-defined and others are less common. Identification
More informationCOLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014
COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS
More informationColonic Polyp. Najmeh Aletaha. MD
Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding
More informationFamilial Adenomatous Polyposis
Familial Adenomatous Polyposis 1 in 10,000 incidence 100 s to 1000 s of colonic adenomas by teens Cancer risk: colon, gastric, duodenum (periampulla), small bowel, pancreas, papillary thyroid, childhood
More informationReplication error phenotype, clinicopathological variables, and patient outcome in Dukes B stage II (T3,N0,M0) colorectal cancer
200 Department of Pathology, Royal College of Surgeons in Ireland, Dublin, Republic of Ireland B Curran EWKay M Leader Department of Biochemistry K Lenehan O Tighe M A Bennett D T Croke Gastroenterology
More informationHereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register Carlos A. Vaccaro, M.D., 1 Fernando Bonadeo, M.D., 1 Analía V. Roverano, M.D., 1 Paivi
More informationCase Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr
Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Professor Yong Loo Lin School of Medicine, National University
More informationFamily history and molecular features of children, adolescents, and young adults with colorectal carcinoma
1146 COLON CANCER Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma C Durno, M Aronson, B Bapat, Z Cohen, S Gallinger... See end of article for
More informationCaring for Patients at Risk for Hereditary Colorectal Cancer
February 05, 2007 By Karen Greco, PhD, RN, ANP [1] About 6% of colorectal cancers are caused by genetic mutations associated with hereditary colorectal cancer syndromes. The most common hereditary cancer
More informationTumor suppressor genes D R. S H O S S E I N I - A S L
Tumor suppressor genes 1 D R. S H O S S E I N I - A S L What is a Tumor Suppressor Gene? 2 A tumor suppressor gene is a type of cancer gene that is created by loss-of function mutations. In contrast to
More informationAllinaHealthSystems 1
Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective
More informationGenetic Testing for Lynch Syndrome
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post-test genetic counseling is
More informationGENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome
GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual
More informationPrior Authorization. Additional Information:
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationReview Article Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
SAGE-Hindawi Access to Research Molecular Biology International Volume 2011, Article ID 256063, 6 pages doi:10.4061/2011/256063 Review Article Relationship between DNA Mismatch Repair Deficiency and Kenta
More informationCAP Laboratory Improvement Programs. Summary of Microsatellite Instability Test Results From Laboratories Participating in Proficiency Surveys
CAP Laboratory Improvement Programs Summary of Microsatellite Instability Test Results From Laboratories Participating in Proficiency Surveys Proficiency Survey Results From 2005 to 2012 Theresa A. Boyle,
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationClinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia
Original Article Obstet Gynecol Sci 2015;58(2):106-111 http://dx.doi.org/10.5468/ogs.2015.58.2.106 pissn 2287-8572 eissn 2287-8580 Clinical significance of mismatch repair genes immunohistochemical expression
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationLynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)
Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary
More informationGenetic Testing for Inherited Susceptibility to Colon Cancer; Including Microsatellite Instability Testing. Original Policy Date
MP 2.04.06 Genetic Testing for Inherited Susceptibility to Colon Cancer; Including Microsatellite Instability Testing Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review
More informationMr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer
Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth
More informationGI EMERGENCIES Acute Abdominal Pain
GI EMERGENCIES Acute Abdominal Pain Marcia Cruz-Correa, MD, PhD, AGAF. FASGE Associate Professor of Medicine, Biochemistry, Surgery Director Translational Research University of Puerto Rico Comprehensive
More informationAccumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas with Widespread Instability in Microsatellite Sequences
American Journal of Pathology, Vol. 153, No. 4, October 1998 Copyright American Society for Investigative Pathology Accumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas
More informationHereditary Cancer Syndromes
Hereditary Cancer Syndromes Nicoleta Voian, MD, MPH Director Clinical Genetics Service Roswell Park Cancer Institute Nicoleta.Voian@Roswellpark.org February 28, 2017 Common Genetics Terms Gene: A hereditary
More informationMolecular markers in colorectal cancer. Wolfram Jochum
Molecular markers in colorectal cancer Wolfram Jochum Biomarkers in cancer Patient characteristics Tumor tissue Normal cells Serum Body fluids Predisposition Diagnostic marker Specific diagnosis Prognostic
More informationIntroduction. Why Do MSI/MMR Analysis?
Clinical Significance Of MSI, KRAS, & EGFR Pathway In Colorectal Carcinoma UCSF & Stanford Current Issues In Anatomic Pathology Introduction Microsatellite instability and mismatch repair protein deficiency
More informationSerrated Polyps and a Classification of Colorectal Cancer
Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram
More informationAsingle inherited mutant gene may be enough to
396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,
More informationFAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry
FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female
More informationHereditary Aspects of Pancreatic Cancer
Pancreatic Cancer Seminar San Francisco, CA Hereditary Aspects of Pancreatic Cancer Genetic Risk Assessment and Counseling for Familial Pancreatic Cancer February 3, 2016 Amie Blanco, MS, CGC Gordon and
More informationPage 1 of 8 TABLE OF CONTENTS
Page 1 of 8 TABLE OF CONTENTS Patient Evaluation and Recommendation..Page 2 Testing and Follow-up..Page 3 Genetic Counseling Referral Criteria.....Page 4-5 Patient Education..Page 6 Suggested Readings...Page
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationFor identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013
For identification, support and follow up related to Familial Gastrointestinal Cancer conditions South Island Cancer Nurses Network September 2013 Who are we? Specialist multidisciplinary team: Nurse coordinators,
More informationHereditary Colorectal Cancer: The Importance of Recognition as a Preventive Measure
768 International Journal of Collaborative Research on Internal Medicine & Public Health Hereditary Colorectal Cancer: The Importance of Recognition as a Preventive Measure Marcus Valadão, José Antonio
More informationTest Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar
Link full download: http://testbankair.com/download/test-bank-for-robbins-cotran-pathologic-basis-of-disease-9th-edition-bykumar-abbas-and-aster Test Bank for Robbins and Cotran Pathologic Basis of Disease
More informationHereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD
Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Living Beyond Cancer A-Z January 12,2019 Hereditary CRC Syndromes Objectives are to discuss the : Most common Hereditary CRC syndromes
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_colon_cancer 5/2004 8/2017 8/2018 8/2017 Description of Procedure or Service Genetic
More informationA636P testing in Ashkenazi Jews
Familial Cancer 3: 223 227, 2004. Ó 2004 Kluwer Academic Publishers. Printed in the Netherlands. A636P testing in Ashkenazi Jews Jose G. Guillem 1, Harvey G. Moore 1, Crystal Palmer 2, Emily Glogowski
More informationMicrosatellite instability is a rare phenomenon in transition from chronic to blastic phase chronic myeloid leukemia
Turkish Journal of Cancer Vol.31/ No. 2/2001 Microsatellite instability is a rare phenomenon in transition from chronic to blastic phase chronic myeloid leukemia H. OGÜN SERCAN, ZEYNEP Y. SERCAN, SEFA
More informationMolecular mechanisms of human carcinogenesis
Cancer: Cell Structures, Carcinogens and Genomic Instability Edited by Leon P. Bignold 2006 Birkhäuser Verlag/Switzerland 321 Molecular mechanisms of human carcinogenesis William B. Coleman 1 and Gregory
More informationfamily syndrome Muir-Torre syndrome: a variant of the cancer genodermatosis. The typical skin tumours include
J Med Genet 1994;31:627-631 Imperial Cancer Research Fund Genetic Epidemiology Laboratory, Ashley Wing, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK N R Hall M A T Williams D T Bishop
More informationInherited colon cancer and other inherited cancer predispositions. Dr Anne De Leener Centre de Génétique Humaine
14.20-15.00 Inherited colon cancer and other inherited cancer predispositions Dr Anne De Leener Centre de Génétique Humaine INHERITED COLORECTAL CANCER (CRC) Colorectal cancer 5% 1% 10% 84% Sporadic Familial
More informationPaul K. Shitabata, M.D. Dermatopathology Institute
Paul K. Shitabata, M.D. Dermatopathology Institute Key Points Subtle dermatologic signs may suggest significant gastrointestinal and systemic disease Check family history Several dermatologic disorders
More informationA Patient s Guide to risk assessment. Hereditary Colorectal Cancer
A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? Overview of Syndromes This workbook is designed to help you decide if hereditary cancer
More informationThe role of hypermethylation of the hmlh1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers
588 Cancer and Immunogenetics Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, John RadcliVe Hospital, Oxford OX3 9DU, UK J M D Wheeler W F Bodmer Department of Medical Genetics,
More informationMolecular biology of colorectal cancer
Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes
More informationGenetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: 2.04.08 Last Review: 1/2019 Origination: 1/2004 Next Review: 1/2020 Policy Blue Cross and Blue Shield of Kansas
More informationGenetics of Hereditary Nonpolyposis Colorectal Cancer
Arch Iranian Med 2006; 9 (4): 381 389 Review Article Genetics of Hereditary Nonpolyposis Colorectal Cancer Seyed Mohammad Akrami MD PhD * Colorectal cancer is a major cause of morbidity and mortality.
More informationAnatomic Molecular Pathology: An Emerging Field
Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty
More informationMedical Policy An Independent Licensee of the Blue Cross and Blue Shield Association
Genetic Testing for Inherited Susceptibility to Colon Cancer Page 1 of 24 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Genetic Testing for Inherited Susceptibility
More informationTest Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar
Link full download:https://getbooksolutions.com/download/test-bank-for-robbinsand-cotran-pathologic-basis-of-disease-9th-edition-by-kumar Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th
More information